Clostridium Difficile Infection: The prescription for health

Clostridium difficile associated disease will resolve when the patient discontinues taking the antibiotics to which he/she has been previously exposed (Nipa, 2010). Administration of a different antibiotic is used to treat the infection (Grossman, 2010). The infection can usually be treated with an appropriate course of about 10 days of antibiotics including metronidazole or vancomycin administered orally (Nipa, 2010). On occasion intravenous vancomycin may be necessary (Gould, 2010). The nurse should ensure patients are not only taking the newly prescribed antibiotic, but also responding to the treatment by showing a decrease in symptoms. Symptoms can recur despite antibiotic therapy, close monitoring is essential. In order to avoid risk of further complications, nursing interventions would include careful assessment of white blood cell count, temperature, and hydration status; meticulous skin care and assistance with bowel elimination given the loose frequent stools; and management of abdominal discomfort (Grossman, 2010).

Clostridium difficile is a spore forming, anaerobic, toxin-producing, gram-positive bacillus that is the most common cause of nosocomial, antibiotic-associated diarrhea (15-25%).1,2,3 The pathogenesis of C. difficile-associated diarrhea (CDAD) is the result of broad spectrum antibiotics, such as clindamycin, flouroquinolones or ceftriaxone, which reduces the population of normal bowel flora and allowing for an overgrowth of C. difficile.1,2 The toxins synthesized by C. difficile, A and B, lead to the inflammation and damage of the intestinal mucosa creating the symptoms of C. difficile infection (CDI). These symptoms can range from asymptomatic carriers, to mild diarrhea to sudden and occasionally deadly colitis. The clinical practice guidelines for the treatment of CDAD recommends the use of metronidazole (MET) and vancomycin (VAN) that is dependent upon the severity of the CDI.1,2,3

Clostridium difficile is an obligate anaerobe, gram positive bacteria that has the ability to form spores. Clostridium difficile is the leading cause of nosocomial antibiotic associated diarrhea worldwide. C. difficile is an opportunist pathogen that utilizes many factors to infect and damage the host, often with overwhelming consequences. Symptoms range in severity from mild diarrhea to pseudomembranous colitis and toxic megacolon, the most severe form of disease, which often results in death (Awad, 2014).

Clostridium difficile involves a gram-positive spore-forming bacterium, which is a normal element of the colon flora in people. The Clostridium difficile can cause antibiotic-associated diarrhea when the competing bacteria in the gut flora are all killed by antibiotic treatment. The Clostridium difficile infection is one of the serious healthcare-related infection and also a rising health care problem. In the early 1970s, the Clostridium difficile has been known to have the ability to cause pseudomembranous colitis. As stated, the infection is the most cause of nosocomial infectious diarrhea (Aktories & Wilkins, 2000). Individuals that are colonized with clostridium difficile serve as the reservoir for infection and this is by contaminating the environment with spores of such bacteria. This will lead to the spread of the organism on the health care worker’s hands or even through the use of medical equipment. In this paper, we are going to focus on the effective prevention strategies for clostridium difficile. What are the effective prevention strategies for clostridium difficile?

Clostridium difficle is an opportunistic bacterium that can overgrow in immunocompromised individuals and become a difficult condition to manage. Clostridium difficle Colitis remains challenging for medical professionals due to the bacteria’s rapidly developing resistant and the immunosuppressed state the patient is in. The bacterial infection is more prevalent in the elderly community and immune compromised individuals in particular

Clostridium difficile (C. difficile) is a pervasive and troublesome bacterium in healthcare. If left untreated it can lead to a plethora of complications—acute, chronic, and even fatal. C. difficile is a gram positive bacillus (with a capsule) and has ideal conditions for growth at around 37°C in an obligate anaerobic environment. In its vegetative state, C. difficile contains multiple flagella for motility within the intestinal tract; 1 however, once outside of its ideal environment, or through active shedding, it’s left latent within its hardy endospore until it is in its ideal environment once again.

Clostridium difficile is a bacterium that is found in the human colonic flora that can cause diarrhea and more serious conditions, such as colitis. This occurs if the physiological bacterial flora is changed or damaged due to prolonged antibiotic use and if the concentration of C. difficile increases significantly. The prolonged antibiotic use enables C. difficile to multiply and produce large amounts of dangerous toxins. Therapy for those who suffer from this includes rehydration, immediate stop of the causative antibiotic (usually clindamycin or amoxicillin), and new antibiotics to reverse the symptoms such as vancomycin. C. difficile is easily transmitted within hospital settings because its spores are resistant to the commonly used alcohol

Clostridium difficile, or C. difficile for short, are words that every healthcare worker hates to hear that their patient has, or may potentially have. This spore forming bacterium has significant healthcare-associated infection potential. An especially virulent strain has affected health care facilities throughout the U.S. and North America in the past few years. What C. difficile is, its symptoms, how it is transmitted, and the prevention transmission are important issues to all healthcare workers. These questions and issues will be covered in this paper.

Each year in the United States, many people require hospitalization due to various medical reasons. Often times, patients must undergo a course of antibiotics to treat the medical condition that warranted the hospitalization. The combination of the necessity to be admitted to a health care facility along with the administration of an antibiotic may result in a Clostridium difficile infection (CDI). The purpose of this paper is to provide an overview of a CDI, including an overview of the microbiology of Clostridium Difficile (C- diff), as well as the epidemiology, pathophysiology, signs, symptoms, treatment and prevention of the infection.

Patients that come in with watery diarrhea are normally tested for Clostridium difficile. Watery diarrhea is the most common sign of an infection that is recurrent for about two to three times a day for mild to moderate infection and in addition to minor abdominal pain. Indications of a severe infection includes severe diarrhea occurring 10 to 15 times a day. More symptoms that a patient with a severe infection caused by Clostridium difficile might present are intolerable abdominal pain, fever, dehydration due to diarrhea, blood and pus in the stool, nausea, and elevated counts of white blood cells (Mayo Clinic Staff, 2013). However, people that are commonly at risk for infection of C. diff should be tested and those patients are ones that

In the United States, Clostridim difficile has cost the healthcare system possible more than 1 billion dollars annually, and in developing countries it is the leading cause of illness that occurred in hospitals; with cases that have C. difficile link to it is estimated to cause over 3600 dollars in health care fees (Heinlen and Ballard, 2010). According to data that was reported by Center for Disease Control and Prevention, C. difficile start from a low of 31 cases out of 100,000 people per yer in 1996 to an increase in 2003 with 61cases out of 100,000 people per year (Heinlen and Ballard, 2010). In the United States alone, it have been estimated that 500,000 cases have occurred per year (Heinlen and Ballard, 2010). C. difficile infections (CDI) have also increased by 25% with an estimate of 15,000- 20,000 people die per year in

Clostridium difficile a gram positive bacteria that is part of human (adult) gut microbiota and that could act as an opportunistic pathogen under certain circumstances such as, some antibiotic therapy and changes in the “normal” gut microbiota. Through this events an opportunistic behavior is activated leading to an infection and its characteristic pathology pseudomembranous colitis, other symptom that is present in some cases of clostridial infection and it hasn't been well documented is neuro degeneration due to C. difficile neurotoxins production. The effects of this toxins in the nervous system and in the development of the pathology is not well characterized. In order to understand not only the development of the pathology but also the role and

Studies have identified different genera of bacteria which are present in the microbiome and their role in nutrient intake. Gut microbiota has 3 main enterotypes Prevotella, Bacteroides and Ruminococcus, there is a strong correlation between the concentration of each bacterial community and the dietary constituents. A diet high in carbohydrates and simple sugars would also indicate and reveal a greater concentration of Prevotella whereas a diet high in protein and animal fats would present a higher concentration of Bacteroides in the gut. A long term change in the diet would permanently shift the concentration of bacteria in the gut to accommodate the new nutrient uptake. This would then change the bacterial barrier in the intestine which could make it more vulnerable due to reduced species richness.

In this article I read that microbes and their colonies play a huge role in our immune system and are literally everywhere on us, a large and very important part are in our gut. The ones in your gut help with diseases and with your health conditions. The epidemic of CDI in Europe and the USA has caused many people to request the treatment of fecal microbiota transplantation because it eradicates CDI. The new interest has been awakened by the investigation into gut microbiota, which is very important in resistant and energy metabolism. Some diseases result from microbiotic related dysfunctions and that is why we should check into FMT for other disorders also.